BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.4% - Here's Why

Key Points

• BioRestorative Therapies' stock (OTCMKTS:BRTXQ) declined by 1.4% during trading, with shares last priced at $1.43.
• The company has a market cap of $2.34 billion and a P/E ratio of -1.34.
• BioRestorative specializes in developing therapeutic products based on adult stem cells, focusing on treatments for disc/spine disease and metabolic disorders.

Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - ) were down 1.4% during trading on Thursday . The stock traded as low as $1.35 and last traded at $1.43. Approximately 31,479 shares were traded during trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $1.45.

BioRestorative Therapies Stock Down 1.4%

The stock has a market cap of $2.34 billion, a P/E ratio of -1.34 and a beta of 102.36. The firm's fifty day moving average price is $1.53 and its 200-day moving average price is $1.65.

About BioRestorative Therapies

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.